KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

Birchview Capital, LP's Holding History (CIK: 0001618205)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 30,000 Value ($000) $1,165 Avg Close — Range —
Q2 2025
Shares 30,000 Value ($000) $830 Avg Close — Range —
Q1 2025
Shares 30,006 Value ($000) $666 Avg Close — Range —
Q4 2024
Shares 30,000 Value ($000) $593 Avg Close — Range —
Q3 2024
Shares 30,000 Value ($000) $750 Avg Close — Range —
Q2 2024
Shares 30,000 Value ($000) $560 Avg Close — Range —
Q1 2024
Shares 30,000 Value ($000) $592 Avg Close — Range —
Q4 2023
Shares 30,000 Value ($000) $526 Avg Close — Range —
Q3 2023
Shares 30,000 Value ($000) $521 Avg Close — Range —
Q2 2023
Shares 30,000 Value ($000) $422 Avg Close — Range —
Q1 2023
Shares 30,000 Value ($000) $0 Avg Close — Range —
Q4 2022
Shares 30,000 Value ($000) $0 Avg Close — Range —
Q3 2022
Shares 30,000 Value ($000) $385 Avg Close — Range —
Q2 2022
Shares 30,000 Value ($000) $291 Avg Close — Range —
Q1 2022
Shares 30,000 Value ($000) $298 Avg Close — Range —
Q4 2021
Shares 30,000 Value ($000) $353 Avg Close — Range —
Q3 2021
Shares 30,000 Value ($000) $342 Avg Close — Range —
Q2 2021
Shares 20,000 Value ($000) $279 Avg Close — Range —